![Frank Slack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Slack
Grundare på
Impilo Therapeutics, Inc.
Profil
Frank J.
Slack is the founder of Redona Therapeutics, Inc. founded in 2016.
Dr. Slack is also the founder of Impilo Therapeutics, Inc.,MiraDx, Inc. Dr. Slack is currently a Professor at Yale University.
Aktiva positioner av Frank Slack
| Företag | Position | Start |
|---|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2010-07-05 |
Impilo Therapeutics, Inc.
 Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Grundare | - |
Tidigare kända positioner av Frank Slack
| Företag | Position | Slut |
|---|---|---|
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Grundare | - |
MiraDx, Inc.
 MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Grundare | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
97
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiraDx, Inc.
MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Health Services |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Health Technology |
Impilo Therapeutics, Inc.
Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Technology Services |
